Europe Immunodiagnostics Market to 2030 - By Size, Share, Growth by End User and Forecast

1. Introduction

1.1 Scope of the Study

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 Europe Immunodiagnostics Market – by Product

1.3.2 Europe Immunodiagnostics Market – by Clinical Indication

1.3.3 Europe Immunodiagnostics Market – by End User

1.3.4 Europe Immunodiagnostics Market – by Country

2. Europe Immunodiagnostics Market – Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. Europe Immunodiagnostics Market – Market Landscape

4.1 Overview

4.2 Europe PEST Analysis

4.3 Expert’s Opinion

5. Europe Immunodiagnostics Market – Key Market Dynamics

5.1 Market Drivers

5.1.1 Increasing Prevalence of Infectious Diseases

5.1.2 Growing Use of Point-of-Care Immunodiagnostics

5.2 Market Restraints

5.2.1 Inadequate Reimbursement Scenario

5.3 Market Opportunities

5.3.1 Rising Focus on R&D Investment and Expansion by Key Players

5.4 Future Trends

5.4.1 Technological Advancements in Immunodiagnostics

5.5 Impact Analysis

6. Immunodiagnostics Market – Europe Analysis

6.1 Europe Immunodiagnostics Market Revenue Forecast and Analysis

7. Europe Immunodiagnostics Market Analysis – by Product

7.1 Overview

7.2 Europe Immunodiagnostics Market, By Product, 2022 & 2030 (%)

7.3 Enzyme-linked Immunosorbent Assays (ELISA)

7.3.1 Overview

7.3.2 Enzyme-linked Immunosorbent Assays (ELISA): Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

7.4 Chemiluminescence Immunoassays (CLIA)

7.4.1 Overview

7.4.2 Chemiluminescence Immunoassays (CLIA): Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

7.4.3 Vitamin D Assay

7.4.3.1 Overview

7.4.3.2 Vitamin D Assay: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

7.4.4 HIV Detection

7.4.4.1 Overview

7.4.4.2 HIV Detection: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

7.4.5 HIV Ag/Ab Combo assay

7.4.5.1 Overview

7.4.5.2 HIV Ag/Ab Combo Assay: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

7.4.6 Other Tests

7.4.6.1 Overview

7.4.6.2 Other Tests: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

7.5 Radioimmunoassays (RIA)

7.5.1 Overview

7.5.2 Radioimmunoassays (RIA): Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

7.6 Others

7.6.1 Overview

7.6.2 Others: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

8. Europe Immunodiagnostics Market Analysis – Clinical Indication

8.1 Overview

8.2 Europe Immunodiagnostics Market Share by Clinical Indication - 2022 & 2030 (%)

8.3 Infectious Diseases:

8.3.1 Overview

8.3.2 Infectious Diseases: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

8.3.2.1 COVID-19

8.3.2.1.1 Overview

8.3.2.1.2 COVID-19: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

8.3.2.2 Tuberculosis

8.3.2.2.1 Overview

8.3.2.2.2 Tuberculosis: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

8.3.2.3 Lyme

8.3.2.3.1 Overview

8.3.2.3.2 Lyme: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

8.3.2.4 Infection Management

8.3.2.4.1 Overview

8.3.2.4.2 Infection Management: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

8.3.2.5 Zika

8.3.2.5.1 Overview

8.3.2.5.2 Zika: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

8.3.2.6 Treponema

8.3.2.6.1 Overview

8.3.2.6.2 Treponema: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

8.3.2.7 TORCH

8.3.2.7.1 Overview

8.3.2.7.2 TORCH: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

8.3.2.8 Measles and Mumps

8.3.2.8.1 Overview

8.3.2.8.2 Measles and Mumps: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

8.3.2.9 VZV

8.3.2.9.1 Overview

8.3.2.9.2 VZV: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

8.3.2.10 EBV

8.3.2.10.1 Overview

8.3.2.10.2 EBV: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

8.4 Hepatitis+HIV:

8.4.1 Overview

8.4.2 Hepatitis+HIV: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

8.5 Gastrointestinal

8.5.1 Overview

8.5.2 Gastrointestinal: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

8.6 Metabolic Disorders

8.6.1 Overview

8.6.2 Metabolics: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

8.7 Endocrinology

8.7.1 Overview

8.7.2 Endocrinology: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

8.7.3 Hypertension

8.7.3.1 Overview

8.7.3.2 Hypertension: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

8.7.4 Growth

8.7.4.1 Overview

8.7.4.2 Growth: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

8.7.5 Diabetes

8.7.5.1 Overview

8.7.5.2 Diabetes:Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

8.7.6 Thyroid

8.7.6.1 Overview

8.7.6.2 Thyroid: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

8.7.7 Reproductive Endocrinology

8.7.7.1 Overview

8.7.7.2 Reproductive Endocrinology: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

8.8 Others

8.8.1 Overview

8.8.2 Others: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

9. Europe Immunodiagnostics Market Analysis – End User

9.1 Overview

9.2 Europe Immunodiagnostics Market Share by End User - 2022 & 2030 (%)

9.3 Hospitals

9.3.1 Overview

9.3.2 Hospitals: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

9.4 Clinics

9.4.1 Overview

9.4.2 Clinics: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

9.5 Diagnostic Laboratories

9.5.1 Overview

9.5.2 Diagnostic Laboratories: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

9.6 Academic and Research Institutes

9.6.1 Overview

9.6.2 Academic and Research Institutes: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

9.7 Others

9.7.1 Overview

9.7.2 Others: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

10. Europe Immunodiagnostics Market – Revenue and Forecast to 2030 – Country Analysis

10.1 Overview

10.1.1.1 UK: Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)

10.1.1.1.1 Overview

10.1.1.1.2 UK: Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)

10.1.1.1.3 UK: Immunodiagnostics Market, by Product, 2020–2030 (US$ Million)

10.1.1.1.3.1 UK: Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)– Revenue and Forecast to 2030 (US$ Million)

10.1.1.1.4 UK: Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2030 (US$ Million)

10.1.1.1.4.1 UK: Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2030 (US$ Million)

10.1.1.1.4.2 UK: Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2030 (US$ Million)

10.1.1.1.5 UK: Immunodiagnostics Market, by End User, 2020–2030 (US$ Million)

10.1.1.2 Germany: Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)

10.1.1.2.1 Overview

10.1.1.2.2 Germany: Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)

10.1.1.2.3 Germany: Immunodiagnostics Market, by Product, 2020–2030 (US$ Million)

10.1.1.2.3.1 Germany: Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)– Revenue and Forecast to 2030 (US$ Million)

10.1.1.2.4 Germany: Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2030 (US$ Million)

10.1.1.2.4.1 Germany: Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2030 (US$ Million)

10.1.1.2.4.2 Germany: Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2030 (US$ Million)

10.1.1.2.5 Germany: Immunodiagnostics Market, by End User, 2020–2030 (US$ Million)

10.1.1.3 France: Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)

10.1.1.3.1 Overview

10.1.1.3.2 France: Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)

10.1.1.3.3 France: Immunodiagnostics Market, by Product, 2020–2030 (US$ Million)

10.1.1.3.3.1 France: Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)– Revenue and Forecast to 2030 (US$ Million)

10.1.1.3.4 France: Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2030 (US$ Million)

10.1.1.3.4.1 France: Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2030 (US$ Million)

10.1.1.3.4.2 France: Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2030 (US$ Million)

10.1.1.3.5 France: Immunodiagnostics Market, by End User, 2020–2030 (US$ Million)

10.1.1.4 Italy: Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)

10.1.1.4.1 Overview

10.1.1.4.2 Italy: Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)

10.1.1.4.3 Italy: Immunodiagnostics Market, by Product, 2020–2030 (US$ Million)

10.1.1.4.3.1 Italy: Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)– Revenue and Forecast to 2030 (US$ Million)

10.1.1.4.4 Italy: Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2030 (US$ Million)

10.1.1.4.4.1 Italy: Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2030 (US$ Million)

10.1.1.4.4.2 Italy: Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2030 (US$ Million)

10.1.1.4.5 Italy: Immunodiagnostics Market, by End User, 2020–2030 (US$ Million)

10.1.1.5 Spain: Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)

10.1.1.5.1 Overview

10.1.1.5.2 Spain: Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)

10.1.1.5.3 Spain: Immunodiagnostics Market, by Product, 2020–2030 (US$ Million)

10.1.1.5.3.1 Spain: Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)– Revenue and Forecast to 2030 (US$ Million)

10.1.1.5.4 Spain: Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2030 (US$ Million)

10.1.1.5.4.1 Spain: Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2030 (US$ Million)

10.1.1.5.4.2 Spain: Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2030 (US$ Million)

10.1.1.5.5 Spain: Immunodiagnostics Market, by End User, 2020–2030 (US$ Million)

10.1.1.6 Rest of Europe: Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)

10.1.1.6.1 Overview

10.1.1.6.2 Rest of Europe: Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)

10.1.1.6.3 Rest of Europe: Immunodiagnostics Market, by Product, 2020–2030 (US$ Million)

10.1.1.6.3.1 Rest of Europe: Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)– Revenue and Forecast to 2030 (US$ Million)

10.1.1.6.4 Rest of Europe: Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2030 (US$ Million)

10.1.1.6.4.1 Rest of Europe: Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2030 (US$ Million)

10.1.1.6.4.2 Rest of Europe: Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2030 (US$ Million)

10.1.1.6.5 Rest of Europe: Immunodiagnostics Market, by End User, 2020–2030 (US$ Million)

11. Europe Immunodiagnostics Market –Industry Landscape

11.1 Overview

11.2 Inorganic Growth Strategies

11.2.1 Overview

11.3 Organic Growth Strategies

11.3.1 Overview

12. Company Profiles

12.1 Abbott Laboratories

12.1.1 Key Facts

12.1.2 Business Description

12.1.3 Products and Services

12.1.4 Financial Overview

12.1.5 SWOT Analysis

12.1.6 Key Developments

12.2 F. Hoffmann-La Roche Ltd

12.2.1 Key Facts

12.2.2 Business Description

12.2.3 Products and Services

12.2.4 Financial Overview

12.2.5 SWOT Analysis

12.2.6 Key Developments

12.3 DiaSorin SpA

12.3.1 Key Facts

12.3.2 Business Description

12.3.3 Products and Services

12.3.4 Financial Overview

12.3.5 SWOT Analysis

12.3.6 Key Developments

12.4 Danaher Corp

12.4.1 Key Facts

12.4.2 Business Description

12.4.3 Products and Services

12.4.4 Financial Overview

12.4.5 SWOT Analysis

12.4.6 Key Developments

12.5 Thermo Fisher Scientific Inc

12.5.1 Key Facts

12.5.2 Business Description

12.5.3 Products and Services

12.5.4 Financial Overview

12.5.5 SWOT Analysis

12.5.6 Key Developments

12.6 PerkinElmer Inc

12.6.1 Key Facts

12.6.2 Business Description

12.6.3 Products and Services

12.6.4 Financial Overview

12.6.5 SWOT Analysis

12.6.6 Key Developments

12.7 Shenzhen Mindray Bio-Medical Electronics Co., Ltd.

12.7.1 Key Facts

12.7.2 Business Description

12.7.3 Products and Services

12.7.4 Financial Overview

12.7.5 SWOT Analysis

12.7.6 Key Developments

12.8 bioMerieux SA

12.8.1 Key Facts

12.8.2 Business Description

12.8.3 Products and Services

12.8.4 Financial Overview

12.8.5 SWOT Analysis

12.8.6 Key Developments

12.9 Svar Life Science AB

12.9.1 Key Facts

12.9.2 Business Description

12.9.3 Products and Services

12.9.4 Financial Overview

12.9.5 SWOT Analysis

12.9.6 Key Developments

12.10 Siemens Healthcare GmbH

12.10.1 Key Facts

12.10.2 Business Description

12.10.3 Products and Services

12.10.4 Financial Overview

12.10.5 SWOT Analysis

12.10.6 Key Developments

13. Appendix

13.1 About The Insight Partners

13.2 Glossary of Terms

LIST OF TABLES

Table 1. UK Immunodiagnostics Market, by Product – Revenue and Forecast to 2030 (US$ Million)

Table 2. UK Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)– Revenue and Forecast to 2030 (US$ Million)

Table 3. UK Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2030 (US$ Million)

Table 4. UK Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2030 (US$ Million)

Table 5. UK Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2030 (US$ Million)

Table 6. UK Immunodiagnostics Market, by End User – Revenue and Forecast to 2030 (US$ Million)

Table 7. Germany Immunodiagnostics Market, by Product – Revenue and Forecast to 2030 (US$ Million)

Table 8. Germany Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)– Revenue and Forecast to 2030 (US$ Million)

Table 9. Germany Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2030 (US$ Million)

Table 10. Germany: Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2030 (US$ Million)

Table 11. Germany Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2030 (US$ Million)

Table 12. Germany Immunodiagnostics Market, by End User – Revenue and Forecast to 2030 (US$ Million)

Table 13. France Immunodiagnostics Market, by Product – Revenue and Forecast to 2030 (US$ Million)

Table 14. France Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)– Revenue and Forecast to 2030 (US$ Million)

Table 15. France Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2030 (US$ Million)

Table 16. France: Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2030 (US$ Million)

Table 17. France Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2030 (US$ Million)

Table 18. France Immunodiagnostics Market, by End User – Revenue and Forecast to 2030 (US$ Million)

Table 19. Italy Immunodiagnostics Market, by Product – Revenue and Forecast to 2030 (US$ Million)

Table 20. Italy Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)– Revenue and Forecast to 2030 (US$ Million)

Table 21. Italy Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2030 (US$ Million)

Table 22. Italy: Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2030 (US$ Million)

Table 23. Italy Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2030 (US$ Million)

Table 24. Italy Immunodiagnostics Market, by End User – Revenue and Forecast to 2030 (US$ Million)

Table 25. Spain Immunodiagnostics Market, by Product – Revenue and Forecast to 2030 (US$ Million)

Table 26. Spain Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)– Revenue and Forecast to 2030 (US$ Million)

Table 27. Spain Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2030 (US$ Million)

Table 28. Spain: Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2030 (US$ Million)

Table 29. Spain Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2030 (US$ Million)

Table 30. Spain Immunodiagnostics Market, by End User – Revenue and Forecast to 2030 (US$ Million)

Table 31. Rest of Europe Immunodiagnostics Market, by Product – Revenue and Forecast to 2030 (US$ Million)

Table 32. Rest of Europe Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)– Revenue and Forecast to 2030 (US$ Million)

Table 33. Rest of Europe Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2030 (US$ Million)

Table 34. Rest of Europe: Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2030 (US$ Million)

Table 35. Rest of Europe Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2030 (US$ Million)

Table 36. Rest of Europe Immunodiagnostics Market, by End User – Revenue and Forecast to 2030 (US$ Million)

Table 37. Recent Inorganic Growth Strategies in the Europe immunodiagnostics market

Table 38. Recent Organic Growth Strategies in the Europe immunodiagnostics market

Table 39. Glossary of Terms, Europe Immunodiagnostics Market

LIST OF FIGURES

Figure 1. Europe Immunodiagnostics Market Segmentation

Figure 2. Europe Immunodiagnostics Market, by Country

Figure 3. Europe Immunodiagnostics Market Overview

Figure 4. Enzyme-Linked Immunosorbent Assays (ELISA) Segment Held Largest Share of Product Segment in Europe Immunodiagnostics Market

Figure 5. The UK Expected to Show Remarkable Growth During Forecast Period

Figure 6. Europe: PEST Analysis

Figure 7. Experts’ Opinion

Figure 8. Europe Immunodiagnostics Market: Impact Analysis of Drivers and Restraints

Figure 9. Europe Immunodiagnostics Market – Revenue Forecast and Analysis – 2021–2030

Figure 10. Europe Immunodiagnostics Market, by Product, 2022 & 2030 (%)

Figure 11. Enzyme-linked Immunosorbent Assays (ELISA): Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

Figure 12. Chemiluminescence Immunoassays (CLIA): Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

Figure 13. Vitamin D Assay: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

Figure 14. HIV Detection: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

Figure 15. HIV Ag/Ab Combo Assay: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

Figure 16. Other Tests: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

Figure 17. Radioimmunoassays (RIA): Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

Figure 18. Others: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

Figure 19. Europe Immunodiagnostics Market Share by Clinical Indication - 2022 & 2030 (%)

Figure 20. Infectious Diseases: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

Figure 21. COVID-19: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

Figure 22. Tuberculosis: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

Figure 23. Lyme: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

Figure 24. Infection Management: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

Figure 25. Zika: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

Figure 26. Treponema: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

Figure 27. TORCH: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

Figure 28. Measles and Mumps: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

Figure 29. VZV: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

Figure 30. EBV: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

Figure 31. Hepatitis+HIV: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

Figure 32. Gastrointestinal: Europe Immunodiagnostics Market Revenue and Forecasts to 2030 (US$ Million)

Figure 33. Metabolics: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

Figure 34. Endocrinology: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

Figure 35. Hypertension: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

Figure 36. Growth: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

Figure 37. Diabetes: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

Figure 38. Thyroid: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

Figure 39. Reproductive Endocrinology: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

Figure 40. Endocrinology: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

Figure 41. Europe Immunodiagnostics Market Share by End User - 2022 & 2030 (%)

Figure 42. Hospitals: Europe Immunodiagnostics Market Revenue and Forecasts to 2030 (US$ Million)

Figure 43. Clinics: Europe Immunodiagnostics Market Revenue and Forecasts To 2030 (US$ Million)

Figure 44. Diagnostic Laboratories: Europe Immunodiagnostics Market Revenue and Forecasts to 2030 (US$ Million)

Figure 45. Academic and Research Institutes: Europe Immunodiagnostics Market Revenue and Forecasts to 2030 (US$ Million)

Figure 46. Others: Europe Immunodiagnostics Market Revenue and Forecasts to 2030 (US$ Million)

Figure 47. Europe: Immunodiagnostics Market, by Key Country – Revenue (2022) (US$ Million)

Figure 48. Europe: Immunodiagnostics Market, by Country, 2022 & 2030 (%)

Figure 49. UK: Immunodiagnostics market – Revenue and Forecast to 2030 (US$ Million)

Figure 50. Germany: Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)

Figure 51. France: Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)

Figure 52. Italy: Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)

Figure 53. Spain: Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)

Figure 54. Rest of Europe: Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)